Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting

Inclusion Criteria:

• Men and women aged ≥18 years;
• Cardiology patients who has been prescribed atorvastatin by physician's clinicaljudgment under normal clinical care. These patients will include those withestablished coronary heart disease, or having multiple risk factors and at risk forcardiovascular disease, or primary hypercholesterolemia.
• Baseline laboratory reports prior to starting atorvastatin therapy can be tracked ,including lipid measurement, liver function, and Creatine Kinase (CK) value. The dateof baseline reports should be within 1 month before taking atorvastatin or within 24hafter starting atorvastatin therapy.
• Evidence of a personally or his/her legally acceptable representative signed and datedinformed consent document indicating that the patient has been informed of allpertinent aspects of the study and accept follow-up visit.

Exclusion Criteria:

• Patients who have regularly taken atorvastatin therapy more than 4 weeks beforeenrollment
• Concomitant any other lipid-lower medication at baseline, or during the studyconduction on physician clinical judgement